Horizons Ventures invests globally in early to growth-stage deep science and disruptive technology companies that address fundamental human challenges, particularly in health, climate adaptation, and social equity.
About Horizons Ventures
Horizons Ventures is the Hong Kong-based investment arm of Li Ka-shing, with a long track record of early bets on companies including Facebook, Spotify, Zoom, and DeepMind. The firm operates with permanent family-office capital and invests across software, deep tech, biotech, and healthcare with a global mandate and unusually long time horizons. Check sizes vary widely from a few million dollars at seed to tens of millions at growth, and Horizons is known for participating alongside top-tier financial leads rather than dictating terms. Healthcare exposure is meaningful but not exclusive, with concentrations in synthetic biology, AI-driven drug discovery, longevity, and selectively digital health. AI focus is genuine and informed by years of investments in foundational AI companies. Founders best suited are Series A and later teams with deep technical defensibility, ambitious global plans, and the ability to handle a strategic investor that asks for less than typical institutional VCs in terms of governance but expects high signal-to-noise in updates. Founders who do not fit include traditional services-heavy healthcare businesses, regional digital health plays without global ambition, and teams seeking a hands-on board lead. The entry path is warm introduction through a portfolio CEO, a top-tier co-investor, or a senior operator in the Horizons orbit. LinkedIn outreach is unlikely to convert without strong reference paths.
Founder reviews
Healthcare AI tools backed by Horizons Ventures
Tools made by companies in Horizons Ventures's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Horizons Ventures's portfolio not currently in our directory.
- Juvena Therapeutics · 2022
- MeMed · 2018
- Cortical Labs · 2023
- Carmot Therapeutics · 2018
- Kimia Therapeutics · 2023
Team
Pitch / review this investor
Have you raised from Horizons Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).